EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX)

39 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q2 2014.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,739,800 shares of 13,080,549 outstanding shares and own 13.3% of the company stock.
Largest 10 shareholders include Park West Asset Management LLC (426,900 shares), Cormorant Asset Management, LLC (400,000 shares), DEERFIELD MANAGEMENT CO (284,653 shares), WALL STREET ASSOCIATES (200,000 shares), Allianz Asset Management AG (123,044 shares), FARALLON CAPITAL MANAGEMENT LLC (100,000 shares), JENNISON ASSOCIATES LLC (75,836 shares), NORTHERN TRUST CORP (31,024 shares), SUNRISE PARTNERS LIMITED PARTNERSHIP /CT (14,363 shares), and BANQUE PICTET & CIE SA (13,587 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.